Minerva Neurosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Minerva Neurosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.000.000.000.0041.180.000.00
Cost of Revenue11.9012.7114.6516.8422.040.000.00
Gross Profit-11.90-12.71-14.65-16.8419.140.000.00
Operating Expenses
Research & Development11.9012.7114.6532.0422.0458.1234.89
Selling, General & Administrative9.9510.4110.5813.3317.2917.7416.84
Operating Expenses9.9523.1225.2313.3317.29-75.8751.73
Operating Income-21.85-23.12-25.23-30.171.85-75.87-51.73
Other Income/Expense
Interest Income1.271.440.560.020.160.000.00
Interest Expense-4.568.287.41-6.330.000.000.11
Other Income/Expense26.581.400.53-0.02-41.18-19.001.67
Income
Income Before Tax1.44-21.72-32.11-51.711.94-74.44-50.17
Income Tax Expense0.000.000.00-1.800.00-2.250.00
Net Income1.44-30.01-32.11-49.911.94-72.18-50.17
Net Income - Continuous Operations1.44-30.01-32.11-49.910.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-21.84-29.97-24.69-30.151.86-74.28-50.04
EBIT-21.85-30.01-24.70-30.171.85-74.44-50.06
Depreciation & Amortization0.010.030.010.020.020.000.00
Earnings Per Share
Basic EPS--5.00-6.00-9.00---1.00
Diluted EPS--5.00-6.00-9.00--15.00-1.00
Basic Shares Outstanding7.576.515.345.345.104.8838.79
Diluted Shares Outstanding7.576.515.345.345.114.8838.79